Plan lidocaine and bupivacaine dosing for a hair transplant case: weight-based ceilings, combined (additive) amide toxicity, allocation across nerve blocks, tumescent solution, and intradermal touch-ups — with a copy-ready dose summary for the operative note.
Local anesthetic systemic toxicity (LAST) is arguably the highest-consequence preventable risk in office-based hair restoration surgery. Cases run long, the scalp is one of the most vascular fields in the body, and total infiltrated volumes are large — yet many practices still dose by habit ("a few syringes of one percent") rather than by a running milligram ledger. This planner replaces the habit with arithmetic: enter the patient's weight and the planned bupivacaine, and it returns the remaining lidocaine allowance and how the planned solutions consume it.
Randomized trial data in cutaneous surgery show that dilute lidocaine performs far better than tradition suggests — 0.25% with epinephrine was non-inferior to 0.5% for Mohs surgery and excisions, and dermal anesthesia has been demonstrated below 0.1% when epinephrine is present and the solution is given time to dwell. The practical consequence for hair restoration: reserve 1% (buffered) for the named nerve blocks where dense, fast onset matters; let a dilute, buffered, epinephrine-containing tumescent solution provide field turgor and finish dermal coverage; and keep a small buffered 0.25% vial for intradermal touch-ups. Long-acting bupivacaine is budgeted separately and subtracted from the lidocaine allowance by the fractional method, because amide toxicity is additive.
Set the case type (FUE or FUT), patient weight, planned Marcaine volume, and a safety margin — the default plans to 75% of labeled maxima, which leaves headroom for the unplanned. Adjust the three lidocaine lines to your own protocol volumes; the tool converts everything to milligrams, checks it against the budget, and totals the 1% stock required to prepare the case. "Copy plan to clipboard" produces a documentation-ready summary, including the dosing basis and safety measures, for the operative note.